Physician profile
Beth C Weber
NPI 1942227483
$1,758.04
in general payments reported to CMS, 2019-2025
27 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.06 · 2022: $17.48 · 2023: $191 · 2024: $507 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,727.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.88 | 2023-2025 | |
| Lilly USA, LLC | $259.59 | 2023-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $178.48 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $176.71 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $85.15 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.02 | 2025 | Caplyta |
| Boston Scientific Corporation | $52.00 | 2022-2024 | Bodyguardian |
| Collegium Pharmaceutical, INC. | $48.39 | 2025 | Jornay Pm |
| Edwards Lifesciences Corporation | $37.52 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $35.54 | 2023-2024 | Xarelto, Spravato |
| Phathom Pharmaceuticals, INC. | $32.00 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.14 | 2024-2025 | Xifaxan |
| Convatec INC. | $28.22 | 2023 | |
| Exact Sciences Corporation | $25.59 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $22.17 | 2024 | Prolia, Evenity |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.89 | 2023 | |
| Dexcom, INC. | $21.13 | 2025 | Dexcom G6 Transmitter |
| Ironshore Pharmaceuticals INC. | $19.29 | 2024 | |
| Phadia US INC. | $19.17 | 2025 | Immunocap |
| Abbott Laboratories | $19.17 | 2025 | Freestyle Libre 3 |
| Tactile Systems Technology INC | $17.30 | 2023 | Entre Plus, Flexitouch Plus |
| Takeda Pharmaceuticals U.S.A., INC. | $17.11 | 2025 | Trintellix |
| Corium, LLC | $15.42 | 2023 | Azstarys |
| Currax Pharmaceuticals LLC | $15.30 | 2024 | Contrave |
| Pfizer INC. | $14.01 | 2025 | |
| Axsome Therapeutics, INC. | $13.79 | 2025 | Symbravo |
| Insulet Corporation | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.